Free Trial

Shield Therapeutics (STX) Competitors

Shield Therapeutics logo
GBX 7.10 -0.65 (-8.41%)
As of 11:54 AM Eastern

STX vs. ELX, TAO, APC, DGI, IDEA, ANCR, VLG, EAH, DNL, and PXS

Should you be buying Shield Therapeutics stock or one of its competitors? The main competitors of Shield Therapeutics include El Oro (ELX), TAO Alpha (TAO), Apc Technology Group (APC), DG Innovate (DGI), Ideagen (IDEA), Animalcare Group (ANCR), Venture Life Group (VLG), ECO Animal Health Group (EAH), Diurnal Group (DNL), and Provexis (PXS).

Shield Therapeutics vs. Its Competitors

Shield Therapeutics (LON:STX) and El Oro (LON:ELX) are both small-cap computer hardware companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, media sentiment, valuation, risk, dividends, analyst recommendations, institutional ownership and earnings.

El Oro has a net margin of 0.00% compared to Shield Therapeutics' net margin of -173.43%. El Oro's return on equity of 0.00% beat Shield Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Shield Therapeutics-173.43% -470.50% -47.85%
El Oro N/A N/A N/A

11.9% of Shield Therapeutics shares are owned by institutional investors. 62.2% of Shield Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

El Oro has lower revenue, but higher earnings than Shield Therapeutics. Shield Therapeutics is trading at a lower price-to-earnings ratio than El Oro, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Shield Therapeutics£20.92M3.35-£36.28M-£3.88-1.83
El Oro-£7.25M0.00N/A-£2.50N/A

In the previous week, Shield Therapeutics had 2 more articles in the media than El Oro. MarketBeat recorded 2 mentions for Shield Therapeutics and 0 mentions for El Oro. El Oro's average media sentiment score of 0.00 beat Shield Therapeutics' score of -0.18 indicating that El Oro is being referred to more favorably in the news media.

Company Overall Sentiment
Shield Therapeutics Neutral
El Oro Neutral

Summary

Shield Therapeutics and El Oro tied by winning 5 of the 10 factors compared between the two stocks.

Get Shield Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for STX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

STX vs. The Competition

MetricShield TherapeuticsDrug Manufacturers IndustryMedical SectorLON Exchange
Market Cap£70.05M£2.19B£5.75B£3.17B
Dividend YieldN/A2.92%3.95%5.04%
P/E Ratio-1.834.3631.45169.23
Price / Sales3.35652.73428.19465,108.52
Price / Cash6.3610.3737.7527.93
Price / Book129.7111.3910.536.89
Net Income-£36.28M£20.70B£3.27B£5.89B
7 Day Performance-13.96%1.05%1.04%0.24%
1 Month Performance60.41%5.34%5.74%50.01%
1 Year Performance61.32%5.31%50.88%150.48%

Shield Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
STX
Shield Therapeutics
N/AGBX 7.10
-8.4%
N/A+75.2%£70.05M£20.92M-1.8340,000High Trading Volume
ELX
El Oro
N/AN/AN/AN/A£41.06M-£7.25M-26.001,122
TAO
TAO Alpha
N/AGBX 7.10
+31.5%
N/A+3,055.6%£26.89MN/A-32.503Gap Up
High Trading Volume
APC
Apc Technology Group
N/AN/AN/AN/A£18.03M£19.20M19.75164,000
DGI
DG Innovate
N/AN/AN/AN/A£1.90M£24.50K-1.25790Gap Down
IDEA
Ideagen
N/AN/AN/AN/A£1.03B£75.28M17,450.009
ANCR
Animalcare Group
N/AGBX 252
-3.1%
N/A-4.7%£172.77M£84.90M4.70220
VLG
Venture Life Group
N/AGBX 58
-1.7%
N/A+21.3%£73.91M£51.77M98.43165
EAH
ECO Animal Health Group
3.5604 of 5 stars
GBX 73.10
-0.5%
GBX 150
+105.2%
-31.8%£49.53M£89.44M47.25234
DNL
Diurnal Group
N/AN/AN/AN/A£46.33M£4.68M-3.2133
PXS
Provexis
N/AGBX 0.71
-2.6%
N/A+11.0%£16.57M£846.98K-26.774Gap Down

Related Companies and Tools


This page (LON:STX) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners